There’s no denying it: The radiopharmaceuticals boom is here to stay. Now, Australia’s Telix Pharmaceuticals is doubling down on the action with plans to roll an academic collaboration into a fresh ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results